Comparing Modern Approaches to CLL Treatment Drugs

Chronic lymphocytic leukemia is considered the most common type of leukemia in adult patients. Over the past five years, approaches to managing this disease have changed significantly. Targeted pharmacotherapy has replaced classical chemotherapy.Modern medications act directly on tumor cells, leaving healthy tissues practically untouched. This makes it possible to control the disease progression far more effectively than before. Physicians increasingly choose a personalized approach, taking into account the patient’s genetic profile.Evolution of Targeted TherapiesBruton’s tyrosine kinase inhibitors play a key role in current protocols. This enzyme is responsible for the survival and proliferation of abnormal B-lymphocytes. Blocking this protein stops disease development at the molecular level.The first generation of such agents showed high efficacy, but caused side effects. Patients quite often complained about cardiac rhythm, elevated blood pressure, or increased bleeding. Because of this, scientists developed more selective next-generation molecules.The second generation of tyrosine kinase inhibitors acts in a targeted manner and hits the mark more precisely. Thanks to this, the ...